Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF and PRP for therapy-resistant diabetic foot ulcers
IRCT20130811014330N9Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, open-label trial of platelet-rich plasma and autologous adipose stromal vascular fraction in diabetic foot ulcer (DFU) (4 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Wound size, Wound depth and 4 more. Started Aug 2023; status: completed.
02
Drugs
platelet-rich plasmaautologous adipose stromal vascular fraction
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on IRCT20130811014330N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130811014330N9.